The Food and Drug Administration on Thursday approved an implantable brain-stimulating device for patients with hard-to-treat epilepsy. The agency said it cleared Neuropace's RNS Stimulator to reduce seizures in epilepsy patients who have not responded well to medications. The device is implanted in the skull beneath the scalp and attaches to one or two wires that send an electrical current to parts of the brain thought to cause seizures.
Help employers find you! Check out all the jobs and post your resume.
